AU3961899A - Chemotherapeutic treatment - Google Patents

Chemotherapeutic treatment

Info

Publication number
AU3961899A
AU3961899A AU39618/99A AU3961899A AU3961899A AU 3961899 A AU3961899 A AU 3961899A AU 39618/99 A AU39618/99 A AU 39618/99A AU 3961899 A AU3961899 A AU 3961899A AU 3961899 A AU3961899 A AU 3961899A
Authority
AU
Australia
Prior art keywords
chemotherapeutic treatment
chemotherapeutic
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU39618/99A
Inventor
Gabi Haddad
Mark James McKeage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Auckland Uniservices Ltd
Original Assignee
Auckland Uniservices Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Auckland Uniservices Ltd filed Critical Auckland Uniservices Ltd
Publication of AU3961899A publication Critical patent/AU3961899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
AU39618/99A 1998-05-04 1999-05-04 Chemotherapeutic treatment Abandoned AU3961899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NZ330350 1998-05-04
NZ33035098 1998-05-04
PCT/NZ1999/000055 WO1999056742A1 (en) 1998-05-04 1999-05-04 Chemotherapeutic treatment

Publications (1)

Publication Number Publication Date
AU3961899A true AU3961899A (en) 1999-11-23

Family

ID=19926696

Family Applications (1)

Application Number Title Priority Date Filing Date
AU39618/99A Abandoned AU3961899A (en) 1998-05-04 1999-05-04 Chemotherapeutic treatment

Country Status (2)

Country Link
AU (1) AU3961899A (en)
WO (1) WO1999056742A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011903D0 (en) * 2000-05-18 2000-07-05 Astrazeneca Ab Combination chemotherapy
EP1946747A1 (en) * 2007-01-17 2008-07-23 Sandoz AG Pharmaceutical composition of improved stability containing taxane derivatives
WO2019144012A1 (en) * 2018-01-18 2019-07-25 Emory University Mast1 and uses for diagnosing and treating cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697752B1 (en) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Antitumor compositions containing taxane derivatives.

Also Published As

Publication number Publication date
WO1999056742A1 (en) 1999-11-11

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU1772399A (en) Well treatment
AUPP328398A0 (en) Remove-a-line
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU8363398A (en) Capotasto
AU2609599A (en) Sensor-coupling
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU3961899A (en) Chemotherapeutic treatment
AU1055399A (en) Rollerboard
AU9347498A (en) Imidazotriazolopyrimidines
AU3347599A (en) Aeromobile
AU5223199A (en) Bathtub-bathseat
AU5524399A (en) Inorgasmia treatment
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AU9218098A (en) Exocyclic-phosphoethanolamines
AU1779099A (en) Heterocyclyl-derivatives
AU4768799A (en) Bookcover
AU2738299A (en) Solution
AUPP217498A0 (en) Disc-anchor

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase